Souhaitez-vous accéder aux communiqués récents ?

Centre for Neuro Skills (CNS), a premier provider of treatment for traumatic and acquired brain injury, has opened its new clinic in Plano, Texas.

BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today...

Bexorg strengthens leadership team with appointment of Sean Murphy, Ph.D., as Chief Technology Officer

Positive topline results announced from Phase 2a clinical trial of RAP-219 in patients with focal onset seizures Phase 2 trial of RAP-219 in bipolar mania enrolling patients and on track, with topline...

Avance Clinical today announced the launch of its Center of Excellence dedicated to central nervous system (CNS) disorders.

Nilo Therapeutics launches with $101 million Series A to target neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer

Austin, TX, USA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Virtual Clinical Trials Market Size, Trends and Insights By Study Design...

BOSTON, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...

Partnership expands momentum for launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Jupiter...

Austin, TX, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Personalized Medicine Market Size, Trends and Insights By Product...